A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 31/00 (2006.01) A61K 38/00 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2633211
The invention relates to agents which possess anti-angiogenic activity and are accordingly useful in methods of treatment of disease states associated with angiogenesis in the animal or human body. More specifically the invention concerns a combination of an antagonist of the biological activity of Angiopoietin-2 and an antagonist of the biological activity of VEGF-A, and/or KDR, and/or Flt1, and uses of such antagonists.
L'invention porte sur des agents à activité antiangiogène et donc utiles dans des méthodes de traitement d'états morbides associés à l'angiogenèse, chez l'animal ou l'homme. L'invention porte sur plus spécifiquement, sur la combinaison d'un antagoniste de l'activité biologique de l'angiopoïétine 2 et d'un antagoniste de l'activité biologique du VEGF-A et/ou du KDR et/ou du Fltl, et sur les utilisations de tels antagonistes.
Blakey David Charles
Brown Jeffrey Lester
Emery Stephen Charles
Astrazeneca Ab
Smart & Biggar
LandOfFree
Combination of angiopoietin-2 antagonist and of vegf-a, kdr... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of angiopoietin-2 antagonist and of vegf-a, kdr..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of angiopoietin-2 antagonist and of vegf-a, kdr... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1418731